Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000930390 | SCV001076042 | benign | not provided | 2018-09-14 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818898 | SCV002065588 | likely benign | not specified | 2018-10-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001818898 | SCV003710721 | uncertain significance | not specified | 2022-07-12 | criteria provided, single submitter | clinical testing | The c.1235G>A (p.R412Q) alteration is located in exon 8 (coding exon 8) of the CFHR4 gene. This alteration results from a G to A substitution at nucleotide position 1235, causing the arginine (R) at amino acid position 412 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |